Clinical Evidence for Treating MS

In a study of 20 patients with multiple sclerosis, it was shown using the PoNS™ device in combination with physical therapy over 14 weeks led to a significant improvement in gait, as compared to physical therapy alone. 95% of all study patients experienced improvement in their gait however, the PoNS Treatment™ group, on average, had 2x improvement in their gait scores1.

Kim Skinner, PT, DPT
Director of Physical Therapy, Helius Medical Technologies

“As a physical therapist involved in the clinical trials for people with MS, I saw improvements in their gait which many expressed had benefit in daily activities, making things like going to the grocery store and walking outside easier and safer. Many reported that the gait improvement helped them regain a sense of independence, which is often affected by this disease.”

What is the clinical evidence supporting PoNS Treatment™ for MS patients?

In a study of 20 patients with multiple sclerosis, it was shown using the PoNS™ device in combination with physical therapy over 14 weeks led to a significant improvement in gait, as compared to physical therapy alone. 95% of all study patients experienced improvement in their gait however, the PoNS Treatment™ group, on average, had 2x improvement in their gait scores¹.

*PoNS is not intended to treat memory impairment. PoNS is intended for use as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS.

Where can I find more information?

Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial

The Journal of NeuroEngineering and Rehabilitation | May 1, 2014

If you are a clinician seeking detailed information regarding the clinical evidence, please contact us.

How do I get in touch with a clinic that offers PoNS Treatment™?

PoNS Treatment™ is exclusively offered by authorized clinics across Canada with more opening soon.

Find a Clinic

PoNS Treatment™ is exclusively offered by authorized clinics.

Download the MS Patient Brochure

For more detailed information about the results of the trials

References:
¹Leonard G, et al. Multiple Sclerosis Journal–Experimental, Translational and Clinical. 2017; 3(1):2055217317690561.